HHS launches $500m universal vaccines initiative
The US government has unveiled a plan to develop broad-spectrum vaccines for pandemic-prone viruses.
Biopharmaceutical Industry
AstraZeneca CEO calls for increased European investment in pharma
Small biotechs shoulder the burdens of an uncertain biopharma sector
MSD’s Gardasil sales slide further due to China constraints
FDA layoffs and priority review programme’s lapse disrupt rare disease pipeline
J&J projects $400m tariff hit but raises sales outlook
Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit
Keros Therapeutics considers sale amid investor pressure
